Defect of Articular Cartilage Clinical Trial
Official title:
Randomized Controlled Trial to Evaluate the Efficacy of a Neocartilage Implant in the Management of ICRS Grade 3 to 4 Articular Cartilage Lesions of the Knee
ISTO Technologies, Inc. is proposing a clinical study with 225 subjects, to establish the safety and efficacy of the Neocartilage Implant for the treatment of ICRS Grade 3 and 4 articular cartilage lesions of the knee compared to microfracture treatment.
In the United States alone, more than 500,000 cartilage lesions per year require some treatment to reduce pain, restore joint mobility, and prevent further damage caused by the progression of osteoarthritis. The lack of effective cartilage repair approaches or products for restoration of defective articular cartilage to its native, hyaline morphology only continues to exacerbate the incidence of osteoarthritis as these initial defects enlarge and degrade over a 10 to 20 year period. The repair of cartilage, especially in the knee, remains a formidable clinical challenge. Regenerative medicine approaches to cartilage repair have only begun to be explored as possible options and there is a clear trend toward biological solutions for the repair and regeneration of damaged or diseased articular cartilage. The study was designed to compare how well the Neocartilage Implant works against the microfracture therapy, a widely used and accepted cartilage repair therapy. Data to be collected include Pain and Function in Daily Living scores, symptoms, Function in Sports and Recreation, and Knee Related Quality of Life. Additionally, MRI and X-rays will be collected to evaluate the cartilage repair progress. These assessments will be used through the five years of post-operative follow-up. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01473199 -
BioPoly RS Knee Registry Study for Cartilage Defect Replacement
|
N/A | |
Active, not recruiting |
NCT01670617 -
DeNovo NT Natural Tissue Graft Stratified Knee Study
|
N/A | |
Active, not recruiting |
NCT01347892 -
DeNovo NT Ankle LDC Study
|
N/A | |
Completed |
NCT02203071 -
Comparison of BioCartilage Versus Marrow Stimulating Procedure for Cartilage Defects of the Knee
|
||
Completed |
NCT01626677 -
Follow-Up Study of CARTISTEM® Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect
|
Phase 3 | |
Active, not recruiting |
NCT02855073 -
Clinical Trial to Compare ReJoinTM to Sodium Hyaluronate Injection for Knee Osteoarthritis Cartilage Defects
|
Phase 2 | |
Completed |
NCT01290991 -
A Study to Evaluate the Safety of Augmentâ„¢ Bone Graft
|
N/A | |
Terminated |
NCT00881023 -
Cartilage Autograft Implantation System (CAIS) for the Repair of Knee Cartilage Through Cartilage Regeneration
|
N/A | |
Terminated |
NCT02542566 -
Protected Versus Early Weight Bearing Post Microfracture Surgery
|
N/A | |
Completed |
NCT02696876 -
Synovium Brushing to Augmented Microfracture for Improved Cartilage Repair
|
N/A | |
Active, not recruiting |
NCT02524509 -
the Safety and Efficacy Evaluation of Chondron Compared With Mircrofracture of Knee
|
Phase 4 | |
Active, not recruiting |
NCT02537067 -
Efficacy and Safety of Chondron (Autologus Chondrocyte) in Patients With Cartilage Defects in Their Ankle
|
Phase 3 | |
Recruiting |
NCT02519881 -
the Efficacy and Safety of a Modified Microfracture Using Collagen Compared to Those of a Simple Microfracture in Ankle
|
Phase 4 | |
Active, not recruiting |
NCT02539030 -
Comparison of Efficacy and Safety of Microfracture and Modified Microfracture
|
Phase 4 | |
Active, not recruiting |
NCT02659215 -
HyaloFAST Trial for Repair of Articular Cartilage in the Knee
|
N/A | |
Terminated |
NCT01410136 -
Chondrofix Osteochondral Allograft Prospective Study
|
N/A | |
Active, not recruiting |
NCT00885729 -
Mesenchymal Stem Cells in a Clinical Trial to Heal Articular Cartilage Defects
|
Phase 1 | |
Terminated |
NCT01246635 -
Smith & Nephew's European Trufit Study
|
N/A |